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Abstract
Background: Type 2 Diabetes Mellitus and central obesity are associated with higher risk of cardiovascular 
diseases especially in women. Lipid profile may reflect dyslipidemia which includes hypertriglyceridemia, increased level of LDL-C, total cholesterol, and reduced HDL-C level in the blood. Patients with central obesity tend to have dyslipidemia compared to those without central obesity counterpart. The study aimed 
at comparing lipid profile in central-obese diabetic women and non–central-obese diabetic women. 
Methods: This study was an analytical study with cross–sectional approach conducted in Dr. Hasan Sadikin General Hospital, Bandung, Indonesia in 2013. A total of 160 data contained of waist circumference (WC) and the level of total cholesterol, triglyceride, HDL-C and LDL-C were obtained from medical record of 
Diabetic patients within the period of January 2010–January 2012. Women patients whose WC of ≥80 cm 
were classified as central obesity while WC of <80 cm were classified as non-central obesity. The t-test was 
used to compare means of different variables, p<0.05 was considered as statistically significant.
Results: Central obese diabetic women when compared to non-central obese diabetic women showed 
statistically significant increase in the level of total cholesterol serum, triglyceride serum and decrease in 
HDL-C serum level (p<0.05). The LDL-C serum level did not show statistical significant difference in the two groups (p>0.05).
Conclusions: Diabetic patients with central obesity tend to have higher level of total cholesterol and triglyceride and lower level of HDL-C compared to diabetic patients without central obesity. 
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IntroductionDiabetes Mellitus (DM) is a common metabolic disorder in the world which is associated with risk of cardiovascular disease especially in women.1 Based on International Diabetes Federation (IDF), there were approximately 366 million DM patients in 2011 and the number was predicted to increase years by years.2 Increasing number of type 2 DM is directly consistent with the increasing 
number of obesity. Obesity can be defined based on body mass index (BMI) and waist circumference (WC). Women patient with 
excessive WC (≥80 cm) can be classified as central obesity.3 Data from Indonesian Basic Health Research (Riset Kesehatan Dasar, 
RISKESDAS) 2007, reported that women had higher number of suffering central obesity 
compared to men.4 Central obesity reflects higher risk of cardiovascular disease than BMI.5 
There is a significant correlation between the accumulation adipocyte tissue with numerous 
abnormality of metabolism and lipid profile.5There is relation between DM and central obesity, even in patient whose BMI is lower than 25 kg/m2.6 Lipid profile in both disease 
would reflect dyslipidemia.7 A study conducted by Nieves et al.8 discovered that patients with higher  level of abdominal fat had higher total cholesterol, triglyceride, and LDL-C; and lower HDL-C compared to patients who had lower abdominal fat. The study aimed at comparing 
lipid profile in central-obese diabetic and non-central-obese diabetic women in Indonesia, especially in Dr. Hasan Sadikin General Hospital, Bandung where the setting and condition are different from the previous 
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MethodsThis study was an analytical study with cross-sectional design conducted in Dr. Hasan Sadikin General Hospital, Bandung Indonesia in 2013. Before its implementation, the aim and the way this study would be conducted had been approved by Health Research 
Ethics Committee Dr. Hasan Sadikin General Hospital, Bandung Indonesia (LB.02.01/
C02/9529/IX/2013). Data were obtained by consecutive sampling from medical records of Diabetic patients within the period of 
January 2010–January 2012. A total of 160 medical records consisting of eighty data of diabetic type-2 women patients were associated with central obesity and eighty data of non-central obese diabetic women 
were taken to assess their lipid profile. Plasma level of total cholesterol, triglyceride, High 
Density Lipoprotein–Cholesterol (HDL-C), 
and Low Density Lipoprotein–Cholesterol (LDL-C) were analyzed. It was decided that the inclusion criteria was newly diagnosed type 2 diabetic women patients with complete medical records consisting of the variables needed for this study. The independent variable was waist circumference (WC) which can be measured from the midpoint between the lower tip of lowest ribs and highest part of iliac crest.5 These data also obtained from medical 
record. Patients who had WC of ≥80 cm were 
classified as central obesity and patients who 
had WC of <80 cm were classified as non-
central obesity.5 Exclusion criteria included pregnancy, receiving insulin treatment, heart failure, renal failure, and cirrhosis. This study 
used Asian cut–off of BMI value calculated as kilograms per meter square.  The reference of serum lipid level was National Cholesterol 
Education Program (NCEP) Adult Treatment III (ATP III) guidelines. The population of the study was normal distribution based on Kolmogorov-Smirnov test. The t-test was used to compare means of variables. Due to 
certain consideration, p<0.05 was considered 
as statistically significant.. 
Results
The most age group of being confirmed 
diabetes mellitus in both groups was 55–64 years group. It can be found that the highest 
proportion of central obese in central obese–diabetic women was also in the same level of age group. Results from this study showed that patient with central obesity tended to have higher BMI score than the patients without central obesity group (Table 1).Frequency of obesity I in central obese patients was forty (50%) whereas obesity II was sixteen (20%) patients. In non-central obese diabetic group, it was found that more than 50% of them had normal BMI score. Only eighteen (22.5%) respondents of non-central 
obese diabetic who confirmed as overweight and obese I (Table 2).Results of this study showed that the mean of total cholesterol of the study subject 
was 220.2. This value could be classified as hypercholesteronemia (>200 mg/dl). 
Table 1 Characteristic of Type 2 Diabetic Women Patients as the Study Subject
Age
Waist Circumference (WC)
Total n (%)WC ≥80 cm 
(diabetic women 
with central obesity)
WC <80 cm 
(diabetic women without 
central obesity)AgeMean (SD) 55.9 (8.4) 55.4 (9.8) –Minimum – – 28 yearsMaximum – – 82 years
< 35 years old 2 (2%) 4 (5%) 6 (3.7%)
35–44 years old 3 (4%) 3 (4%) 6 (3.7%)
45–54 years old 27 (34%) 27 (34%) 54 (33.8%)
55–64 years old 34 (42%) 34 (42%) 68 (42.5%)
≥ 65 years old 14 (18%) 12 (15%) 26 (16.3%)
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Frequency of high level of total cholesterol in diabetic with central obesity group was thirty-six (45%) patients while in diabetic without 
central obesity were only twenty-three (29%) patients. The mean of LDL-Cholesterol level of the study subject was in borderline level 
(138.1 mg/dl). Highest proportion of LDL-C level in both groups was in borderline level.The mean of Triglyceride level of study 
subject was in borderline level (167.9 
mg/dl). This value could be classified as hypertriglyceridemia (>150 mg/dl). Highest proportion of triglyceride level in diabetic with central obesity group was in high level meanwhile in diabetic without central obesity group was in optimal group. The HDL cholesterol of most respondents remained 
within normal value. There was only 19% of the study subject who had lower HDL-C level (Table 3).Diabetes mellitus type 2 with central obese patients when compared to type 2-diabetic without central obese subjects 
showed statistically significant increase in the levels of total cholesterol serum (p = 0.042) and triglyceride serum  (p=0.000), while 
HDL-C serum showed significant increase in non-central obese type 2 diabetic patients (p=0.002). Serum LDL-C level did not show 
statistically significant difference in the two group (p=0.l62) (Table 4). A comparison of 
lipid profile of central-obese type 2 diabetic patients and non-central obese type 2 diabetic patients is represented in Figure 1.
DiscussionsBased on the table of age distribution of 
respondents, it can be found that the highest 
proportion of patient who had been confirmed 
DM was 55–64 years group. In central obesity group, the highest proportion also came 
from 55–64 years group. This result was relatively similar to the study by Hillier et al.9 that reported the greater frequency of being diagnosed type 2 DM were respondents within 
56–65 years group (29%) compared to the 
respondents within 46–55 years group (27%). 
It’s likely because women within 55–64 years group were already in their menopause period. 
Estrogen deficiency in menopause women was associated with an increase in abdominal fat.10 Elevated fat accumulation in abdomen, especially visceral fat could lead to peripheral insulin resistant and further lead to DM.11 This 
finding was in contrast with the results from Basic Health Research/Riset Kesehatan Dasar 
(RISKESDAS) in 2007 that stated the highest 
proportion of patients who were classified as 
central obesity was patients in 45–54 years group.4Most of the respondents who suffered DM were non-obese patients based on BMI 
classification. There were 102 (64%) study subjects whose BMI score were under 25. The study by Son et al.12 in Vietnam, and Yoon et al.13 in Korea also stated that most of the patients with type 2 DM in their country were not obese. Recent pathogenesis of type 2 DM found that abnormal insulin secretions might be because of changes in nature morphology of 
β-cells and β-cell loss in these diabetic patients are more prominent than insulin resistance.13 The DM had strong association with impaired of metabolism that caused abnormality of lipid and lipoprotein serum.14  Diabetic patients had 
Table 2 Body Mass Index of Type 2 Diabetic Women Patients 
Body Mass Index 
(BMI) kg/m2
Waist Circumference (WC)
Total n (%)WC ≥80 cm 
(diabetic women with 
central obesity)
WC <80 cm 
(diabetic women without 
central obesity)Mean (SD) 27.1(4.5) 20.9 (2.9) –Minimum – – 14.5Maximum – – 43.6
< 18.5 (Underweight) 0 (0%) 14 (18%) 14 (8.8%)
18.5–22.5 (Normal) 17 (21%) 48 (60%) 65 (40.6%)
23–24.9 (Overweight) 10 (13%) 13 (16%) 23 (14.4%)
25–29.9 (Obesity I) 36 (45%) 5 (6%) 41 (25.6%)>30.00 (Obesity II) 17 (21%) 0 (0%) 17 (10.6%)
≥ 65 years old 14 (18%) 12 (15%) 26 (16.3%)
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higher risk of cardiovascular disease because of dyslipidemia than people without DM.15 The study by Yadav  et al.16 in India showed 
that lipid profile of diabetic was worse than subject control. Triglyceride, total cholesterol 
and LDL-C was significantly higher in diabetic patients, leading to dyslipidemia.17 This study showed the mean of total cholesterol, triglyceride and LDL-C of the subjects were 
reflected as dyslipidemia. Another study by Mahantesh14 in Karnataka,  India also stated that triglyceride, total cholesterol and LDL-C level were higher in diabetic patients while HDL-C was relatively higher in control.14 The triglyceride and total cholesterol were 
significantly higher in central-obese diabetic patients). Nieves et al.8 also found similar 
result in their study that patients with the greater level of abdominal fat had higher total cholesterol, triglyceride, and LDL-C compared to patients who had the minimum abdominal 
fat (p<0.001). The HDL-C level was lower than 
the minimum abdominal fat group (p<0.001). In this study, HDL-C in central obese diabetic 
was also significantly lower than non-central obese diabetic group while LDL-C was higher in central-obese diabetic, but was not 
statistically significant.  The relation between central obesity 
and lipid profile may be explained by the uncommon character of abdominal adipocyte. Lipolytic exertion in abdominal adipocyte is different from the visceral and subcutaneous compartment.18 Lipolytic force in the omental 
Table 3 Lipid Profile in Type 2 Diabetic Women Patients 
Parameters (mg/dl)
Waist Circumference (WC)
Total n (%)WC ≥80 cm 
(diabetic women 
with central obesity)
WC <80 cm 
(diabetic women without 
central obesity)Total Cholesterol
<200 (optimal) 21 (26%) 29 (36%) 50 (31.2%)
200–239 (borderline) 23 (29%) 28 (35%) 51 (31.9%)>240 (high) 36 (45%) 23 (29%) 59 (36.9%)Mean (SD) 220.2 (42.1)LDL Cholesterol
<100 (optimal) 7 (9%) 12 (15%) 19 (11.9%)
100–129 (near optimal) 20 (25%) 24 (30%) 44 (27.5%)
130–159 (borderline) 29 (36%) 30 (38%) 59 (36.9%)
160–189 (high) 18 (23%) 9 (11%) 27 (16.9%)
>190 (very high) 6 (7%) 5 (6%) 11 (6.9%)Mean (SD) 138.1(35.6)Triglyceride
<150 (optimal) 23 (29%) 44 (55%) 67 (41.9%)
150–199 (borderline) 16 (20%) 24 (30%) 40 (25.0%)
200–499 (high) 41 (51%) 12 (15%) 53 (33.1%)>500 (very high) 0 (0%) 0 (0%) 0 (0.0%)Mean (SD) 167.9(64.8)HDL Cholesterol
<40 (low) 16 (20%) 15 (18%) 31 (19.4%)
40–59 (borderline) 58 (73%) 39 (49%) 97 (60.6%)>60 (high) 6 (7%) 26 (33%) 32 (20.0%)Mean(SD) 50.7 (14.7)
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(visceral fat) is more active than in the subcutaneous depot in women because these 
visceral fats are more sensitive to β-adrenergic agonist incitement and less to insulin overriding. Therefore the more free faty acids (FFA) is released directly into liver.18 High level of Interleukin-6 which is generated by visceral fat also plays role in releasing FFA into liver 
by increasing sensitiveness of β-adrenergic-dependent lipolysis. The further effect of those process is hypertriglyceridemia state among central obese patients.18 This explanation 
is related to the result of the study that triglyceride and total cholesterol in central 
obese-diabetic women were significantly higher than non-central obese-diabetic group. This study was in agreement with the study conducted in Pakistan stating that the mean of total cholesterol in obese (BMI>30, waist to 
hip ratio–WHR>0.85 in women, WC>88cm in women) women respondents were higher than 
non-obese (BMI<25, WHR<0.85 in women, 
WC<88 cm in women) women subjects. The mean of triglyceride was also higher in obese-
Figure 1 Comparison of Lipid Profile between Type 2 Diabetic Women with Central Obesity 
    and Type 2 Diabetic Women without Central Obesity
Table 4 Statistical Test of Mean Differences of Lipid Profile of Diabetic Type 2 Women with 
  Central Obesity and without Central Obesity  
Parameters
Waist Circumference (WC)




(diabetic women without 
central obesity)Total CholesterolMean (SD) 226.9 (36.6) 213.4 (46.3) 0.042HDL cholesterolMean (SD) 47.1 (11.1) 54.3 (16.8) 0.002LDL cholesterolMean (SD) 142.0 (33.8) 134.1 (37.2) 0.162TriglycerideMean (SD) 194.3 (61.2) 141.6 (57.5) 0.000
≥ 65 years old 14 (18%) 12 (15%) 26 (16.3%)
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women subject.19 According to this study, HDL-C level in central obese-diabetic patients were 
significantly lower than in non-central obese-diabetic patients. This result was in consistent 
with the study by Nieves et al.8 that stated HDL-C level of patient who had greater abdominal fat were lower than patient who had fewer abdominal fat. A study conducted 
by Shah19 also showed the similar pattern that obese women subjects had lower level of HDL-C compared to non-obese women subjects. Decreased  HDL-C level in serum was associated with hypertriglyceride in central obesity. High concentration of triglyceride-rich lipoprotein caused elevated lipid carriage 
by cholesterol ester transfer protein (CETP) between VLDL particles and LDL as well as HDL particles. Then drained of HDL particles appearingin cholesterol ester and triglyceride 
was dominant.18 Numerous VLDL and HDL-accomodating triglyceride are hydrolyzed by hepatic lipase enzyme which elevates in plasma. Products of those process are small dense LDL and HDL particle and as chain reaction, reduced HDL2 sub fraction is found in patients.18 The LDL-C level between both groups did not 
show significant difference. This finding was in contrast with the study by Nieves et al.8 that showed LDL-C level of patients who had higher 
number of abdominal fat was significantly increased, compared to patients who had 
fewer number of abdominal fat (p<0.001). It is likely because this study could not identify the hsitory of dryg consumption from the medical record of the patients. Consumption of statin in previous treatment could be bias to the level of LDL patients. Another limitation of this study was the subject may have suffered another 
disease that affected the result of lipid profile. However, this condition was not recorded. In conclusion, diabetic women patients with central obesity tend to have higher total cholesterol level, higher triglyceride level and lower HDL-C level compared to non-central obese subject. Prolonged abnormal lipid metabolism in central-obese diabetic patients could lead into serious complication of DM especially cardiovascular mortality. Health dietary food and adequate physical activity can prevent those complication and also improve insulin sensitivity of the patients.18
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